HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The new lenders – JP Morgan, HSBC, and Barclays provided fresh funding
US$ 800 million senior secured notes, the largest high yield debut USD bond issuance from India in the last 10 years
The company plans to add 1700 beds by FY27 through the organic route
Both the India and GCC entities will be operated by separate dedicated management teams
Subscribe To Our Newsletter & Stay Updated